D-0701-2021 Class II Ongoing

Recalled by Pfizer Inc. — New York, NY

Recall Details

Product Type
Drugs
Report Date
August 11, 2021
Initiation Date
June 9, 2021
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
69,6396 bottles

Product Description

Chantix (varenicline) tablets, 1 mg, 56 Tablets, Rx Only, Distributed by Pfizer Labs, Division of Pfizer Inc., NY, NY 10017, Made in Ireland. NDC 0069-0469-56

Reason for Recall

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDAs acceptable interim acceptable intake limit

Distribution Pattern

Nationwide

Code Information

Lots EC9843, Exp 31, Mar 2023; EA6080, Exp. 31, Mar 2023.